America has exceeded one after all countries in new cancer diagnoses, making it a cancer capital of the world.
The US saw 2.4 million new cases of cancer in 2022 and exceeded anything but China, which saw nearly 4.8 million. However, the US saw a higher rate than the Asian country – 1.307 cases per 100,000 people, compared to the 490 per 100,000 of China.
In general, the US has the fifth highest cancer percentage in the world and climbing.
America formed approximately 13 percent of the 19 million cases that were registered worldwide in 2022, more than the combined share from all over Africa (six percent), Latin -America and the Caribbean (seven percent) and Oceania (less than two percent).
And the global diagnoses will only increase, which reaches 35 million a year by 2050.
Lung cancer was most diagnosed in both men and women, responsible for nearly 2.5 million new cases, or one in eight cancers worldwide. In the US, an estimated 236,740 new cases of lung cancer were diagnosed and 130,000 people died.
Breast cancer in women formed 12 percent of the cases worldwide, Colorectal accounted for 10 percent, prostate by seven percent and stomach with five percent.
Cancer is now the most important cause of death among Americans younger than 85, according to the report of the American Cancer Society Society.
Although it remains the second leading cause of death in the US, it has surpassed heart conditions as the top murderer in younger age groups.
The expected peak in new diagnoses of cancer is mainly due to population growth and aging, but experts are increasingly blaming environmental oxins and ultra-processed foods.
And although cancer rates in people younger than 50 rise, in particular colorectal cancer, the disease is still mainly affecting seniors.
“This increase in the cases of projected cancer by 2050 is only due to the aging and growth of the population, assuming that the current incidence rates remain unchanged,” “Senior Principal Scientist at the American Cancer Society, said.
“In particular, the prevalence of important risk factors such as consumption of unhealthy diet, physical inactivity, heavy alcohol consumption and cigarettes smoking increases in many parts of the world and is likely to worsen the future cancer that retains interventions on a large scale.”
Experts warn that the expected increase in cancer cases will result from more than just ageing populations.
Population growth explains part of the increase, but to be prevented risk factors – subscription diet, lack of access to impressions and chemical exposures – also stimulate the disproportionate peaks.
Although the US diagnoses about one in six worldwide cases of cancer, it is good for only seven percent of the deaths worldwide, thanks to advanced treatments and rapid approvals of drugs.
The American Cancer Society reported That almost half of all cases and around 56 percent of cancer deaths took place in 2022 in Asia, where more than 59 percent of the world’s population lives.
The death rates of cancer in Africa and Asia are much higher than cases, partly because cancers are often found late and more difficult to treat.
Europe has more cancer cases and deaths than expected for its population, which means about 20 percent of global cases and deaths, although it has less than 10 percent of the world in the world.
About 20 million cancer cases were diagnosed in 2022, but that number is expected to be by 2050 to more than 35 million cases to more than 35 million cases
Prostate cancer in men is the most diagnosed cancer in 118 countries, followed by lung cancer with both sexes in 33 countries, and rank liver, colorectal and stomach cancer in first place in 11, nine and eight countries respectively.
By 2050, the cases of lung cancer will rise from approximately 2.5 million in 2022 to around four million. The dead will also rise from approximately 1.8 million to around three million.
Worldwide breast cancer cases are expected to rise from 2.3 million to 3.5 million in 2050, with dead rising from 666,000 to 1 million.
Breast cancer is the most common cancer in women (excluding skin cancer), diagnosed in 157 countries, while cervical cancer leads in 25 others. The US saw 288,000 new cases in 2022, projected with more than 319,000 before 2025.
Only 10 cancer types cause more than 60 percent of all cases and deaths worldwide. Peloton leadership is lung cancer (12.4 percent of cases), followed by chest (11.6 percent), Colorectal (9.6 percent), prostate (7.3 percent) and gastric cancer (4.9 percent).
Cases of colorectal cancer will rise by 2050 worldwide from 1.9 million to 3 million, fed by processed diets and rising early cases. In 2023, 19,550 Americans younger than 50 were diagnosed with CRC.
The dead will climb from 904,000 to 1.4 million, especially in regions with poor screening.
While the US diagnoses about one in six worldwide cases of cancer, it is good for only seven percent of the deaths worldwide
In North America, the cases of pancreatic cancer and deaths will increase strongly, with minimal survival improvements. Obesity and diabetes are important drivers.
Prostate cancer will explode – from 1.5 million cases from today to no less than 2.5 million in 2050 – as the world’s population gets older.
The dead will jump from 397,000 to 600,000, which are most difficult to have the Sahara, where life -saving treatments for millions are out of reach.
Cases of liver cancer will rise from 865,000 to 1.2 million. The deaths will remain high and approach a million, due to late detection in poorer parts of the world.
It is on the way to occur more often, fed by the growing struggle of America with obesity, diabetes and heavy drinking and even cases of hepatitis are bound. The deaths will climb in Lockstep, because most patients are diagnosed too late for effective treatment.
Cases of cervical cancer can fall from 660,000 to 500,000 with broader HPV vaccination, but deaths can continue to exist in Africa without better screening. In the meantime, Noord -America could almost eliminate it, thanks to vaccines and early detection.
Cases of stomach cancer will fall slightly as a result of H. Pylori control, but the deaths will continue to exist in regions with limited health care.
Cases of pancreatic cancer will be risen from 511,000 to 800,000, reflecting this increase as a result of poor survival rates.
Cases of esophageal cancer will grow from 511,000 to 700,000, driven by obesity-related adenocarcinoma in rich countries.
While cases in the US rise, cancer deaths decrease thanks to the progress in treatments.
Scientists can now develop immune cells in the laboratory that focus on and kill cancer cells, while crispr-based gene therapies are advanced from the lab to clinical examinations for people with cancer.
Dr. Karen E Knudsen, CEO of the American Cancer Society, said: ‘Insight into the global cancer load is crucial to ensure that everyone gets the chance to prevent, detect, treat and survive cancer.
‘These data offer insight into trends and potential intervention areas and can help in prioritizing discovery efforts worldwide.
#America #world #cancer #capital #cases #country